The potent new adjuvant could be used to help make vaccines against HIV and other infectious diseases.

Boosting the efficiency of single-cell RNA-sequencing helps reveal subtle differences between healthy and dysfunctional cells.

With computer models and lab experiments, researchers are working on a strategy for vaccines that could protect against any influenza virus.

In lab tests, virus-like DNA structures coated with viral proteins provoke a strong immune response in human B cells.

Study finds specific cells in the lungs, nasal passages, and intestines that are more susceptible to infection.